We are focused on elevating the next era of obesity care by advancing a diversified pipeline to provide options for people living with obesity no matter where they are in their treatment journey.
Our Approach
With an obesity-first focus, our pipeline is specifically designed to address critical needs in the current therapeutic landscape.
Our Pipeline
Kailera’s four clinical-stage product candidates leverage multiple GLP-1- based mechanisms of action and routes of administration.
Our Clinical Trials
Learn about Kailera’s ongoing clinical trials for people living with obesity.
Recent Press Releases
May 28, 2026
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 26, 2026
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 13, 2026